Chinese biopharmaceutical manufacturer HighTide Therapeutics is gearing up for an initial public offering (IPO) in Hong Kong, with ambitions to raise HK$278 million (US$35.6 million), [more…]
As the world braces for the uncertainties of the coming year, the Institute of International Finance (IIF) warns of challenges ahead for foreign investors eyeing [more…]
In a significant development, global ratings agency Moody’s has downgraded the outlook on China’s credit rating from “stable” to “negative.” This decision comes on the [more…]
In a significant move toward reshaping global economic dynamics, the central banks of China and Saudi Arabia recently inked their first-ever currency swap agreement. This [more…]
In a bid to boost market stability and support stock prices in a sluggish market, China has introduced a series of new regulations aimed at [more…]
Amidst the ongoing turmoil in the Middle East, Asia’s manufacturing sector faces a new wave of obstacles that threaten its path to recovery. The latest [more…]
In a shocking turn of events, Nvidia Corp (NVDA.O) found itself at the center of a storm as its shares plunged by approximately 5%, reaching [more…]
China’s economy saw a robust resurgence in the third quarter, surpassing expectations with a 4.9% year-on-year GDP growth, positioning it well to achieve its annual [more…]
On Friday, China unveiled a combination of economic statistics that indicated a gradual improvement in the decline of exports and imports, even though persistent deflationary [more…]
During the recently concluded “golden week” holiday, cities throughout China witnessed significant spending surges. However, economists caution that this momentum may dwindle as pent-up demand [more…]
